|
|
Evolutions in the Management of Duchenne Muscular Dystrophy (DMD): Treatment Implications for the Present and Future
Target Audience
This educational activity is intended for healthcare professionals involved in the management of patients with Duchenne Muscular Dystrophy (DMD), including neurologists, neuromuscular specialists, and other members of the healthcare team who care for patients with DMD.
Program Overview
Duchenne muscular dystrophy (DMD) impacts 1 in every 3,500 male births globally, and its progression is both relentless and fatal. However, the rapid advancement in DMD therapies brings hope... |
|
|
Updates on the Evolving Role of Multidisciplinary Care Teams for the Management of Patients with Duchenne Muscular Dystrophy
Target Audience
These educational activities are designed for neurologists, pediatric neurologists, global pharmacists, specialty nurses, genetic counselors, medical geneticists, and other physicians involved in multidisciplinary care teams for DMD management.
Program Overview
This enduring activity focuses on improving the care of patients with Duchenne muscular dystrophy (DMD) with regard to effective diagnosis, referral, and treatment. Additionally, the faculty will aim to present stan... |
|
|
Exploring New Treatment Advances for Acid Sphingomyelinase Deficiency in Adults
STATEMENT OF NEED
Acid sphingomyelinase deficiency (ASMD) is a rare, hereditary lysosomal storage disease with multisystemic manifestations, including splenomegaly, hepatomegaly, interstitial lung disease, dyslipidemia, bone marrow and lymph node involvement, and sometimes neurological and peripheral nerve involvement. While the most severe form of ASMD, infantile neurovisceral ASMD, results in death in early childhood, chronic forms of ASMD have more prolonged survival but are associated w... |
|
|
Case Studies in Multiple Sclerosis and Aging
• Identify the clinical difference between age-related/neurodegenerative cognitive decline and MS-related cognitive impairment.
• Discuss the role of potential biomarkers in identifying coexisting neurodegenerative disorders.
• Explain why it is important for the care team to address comorbid vascular risk factors for cognitive decline, including lifestyle modification and healthy behaviors
https://academycme.org/pdfs/MSAging.pdf |
|
|
Exploring Novel Treatments for Rett Syndrome
STATEMENT OF NEED
Rett syndrome is a rare, debilitating neurodevelopmental disorder almost always associated with a spontaneous mutation in the methyl-CpG-binding protein 2 (MECP2) gene on the X-chromosome. Affected individuals experience loss of purposeful hand skills, abnormalities in gait, loss of spoken language, and stereotypic hand movements, with more severe manifestations including seizures, autistic features, autonomic nervous system dysfunction, breathing abnormalities, sleep dist... |
|
|
Improving the Management of Patients With Duchenne Muscular Dystrophy: Emerging Evidence and Treatment Strategies
Target Audience
This activity is designed to meet the educational needs of health care professionals involved in the management of patients with Duchenne muscular dystrophy (DMD), including neurologists and other neuromuscular specialists, with a portion targeting pediatricians.
Program Overview
Expand your knowledge of DMD by exploring real patient case reviews! Gain a deeper understanding of dystrophin’s role in disease progression, explore the latest clinical trial results across tre... |
|
|
Sharing Real-World Experiences with New Rett Syndrome Therapies
Target Audience
The educational design of this activity addresses the needs of neurologists, pediatric neurologists, and specialty NP/PAs involved in the treatment of patients with Rett syndrome.
Program Overview
Integrating newer agents for the treatment of Rett syndrome into clinical practice can be challenging, particularly in community settings. In this activity, an expert panel will convene featuring a neurologist from an International Rett Syndrome Foundation (IRSF)-designated cente... |
|
|
Distinguishing and Managing Early-Stage Alzheimer’s Disease (AD): Leveraging Interdisciplinary Collaboration for Prompt Identification and Optimal Patient Management
Target Audience
This activity is designed to meet the educational needs of healthcare providers involved in the diagnosis and continued care of patients with Alzheimer’s disease, including neurologists, geriatricians, psychiatrists, primary care physicians, nurses, and other multidisciplinary team members.
Program Overview
This educational activity is designed to provide clinicians who manage patients with Alzheimer’s disease with current information on diagnosis and management, inclu... |
|
|
Teaming Up to Treat Rett Syndrome: The Importance of Fostering a Multidisciplinary Approach to Patient Care
Target Audience
The educational design of this activity addresses the needs of neurologists, pediatric neurologists and specialty NP/PAs involved in the treatment of patients with Rett syndrome.
Program Overview
With newer therapies now available for the treatment of Rett syndrome, it is essential that the challenges of managing patients with rare diseases, such as Rett syndrome in resource-poor areas or “care deserts” be addressed.
Join a neurologist and a gastroenterologist from ... |
|
|
Comprehensive Management of Von Hippel-Lindau Disease: Genetic and Oncological Perspectives
STATEMENT OF NEED
Von Hippel-Lindau disease (VHL) is an autosomal dominant disease in which germline pathogenic variants in the VHL gene predispose individuals to specific types of benign tumors, malignant tumors, and cysts in multiple organs, including clear cell renal cell carcinoma (RCC), renal cysts, central nervous system hemangioblastomas, retinal hemangioblastomas, pancreatic tumors and cysts, endolymphatic sac tumors, and cystadenomas of the epididymis and broad ligament (NIH, 2024). ... |
|
|
Neuropsychiatric Complications of Parkinson’s Disease Psychosis
Target Audience
This activity is designed to meet the educational needs of Neurologists, neurology NPs, neurology PAs.
Program Overview
Join us for a dynamic one-hour CME activity on Parkinson’s Disease Psychosis (PDP) with top experts Mark F. Lew, MD, and Jennifer Hui, MD. Unlock the latest best practices for diagnosing PDP and implementing cutting-edge therapies. The session kicks off with a deep dive into Parkinson’s Disease, covering its prevalence, motor and nonmotor symptoms, an... |
|
|
Penn Radiology Comprehensive Neuroradiology: Imaging Ideals (Streaming Online & USB Flash Drive)
Penn Radiology’s renowned faculty provides a thorough review of best practices in Neuroradiology. Comprehensive Neuroradiology: Imaging Ideals will benefit imagers, neurologists and neurosurgeons with an extremely detailed analysis of anatomy, techniques, modalities and procedures. Worth 23 AMA PRA Category I Credits™, applicable toward Maintenance of Certification requirements.
Topics: Neoplastic and non-neoplastic disorders of the brain, spine, head and neck, acute stroke, trauma, t... |
|